Carcinoid tumor and carcinoid syndrome

Current Opinion in Anaesthesiology

Volumn 16, Issue 3, 2003, Pages 343-347

  Dierdorf, Stephen F ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthesia; Carcinoid; Carcinoid syndrome; Heart disease; Octreotide

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANESTHETIC AGENT; ANGIOPEPTIN; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; APROTININ; BRADYKININ; CATECHOLAMINE; CHROMOGRANIN A; CYPROHEPTADINE; DEXFENFLURAMINE; DOXORUBICIN; ETOMIDATE; FENFLURAMINE; FLUOROURACIL; HISTAMINE; INTERFERON; KALLIKREIN; KETANSERIN; METHYSERGIDE; MOTILIN; OCTREOTIDE; PROSTAGLANDIN; SEROTONIN; SEROTONIN ANTAGONIST; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SUBSTANCE P; TACHYKININ; UNINDEXED DRUG;

ABDOMINAL CRAMP; ANESTHESIA; ANESTHESIST; ARTIFICIAL EMBOLISM; BRADYCARDIA; BRONCHOSPASM; BRONCHUS CARCINOID; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOID; CARCINOID SYNDROME; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG HALF LIFE; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROLYTE DISTURBANCE; HEART VALVE; HUMAN; HYPERGLYCEMIA; HYPOTENSION; LONG TERM CARE; LUNG DISEASE; LUNG INSUFFICIENCY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREMEDICATION; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TRICUSPID VALVE REGURGITATION; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 0037607242     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200306000-00017     Document Type: Review

References (34)

1. de Vries H, Verschueren RCJ, Willemse PHB, et al. Diagnostic, surgical and medical aspects of the midgut carcinoids. Cancer Treat Rev 2002; 28:11-25. This is a comprehensive review of carcinoid tumors.
2. de Perrot M, Spiliopoulos A, Fischer S, et al. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg 2002; 73:675-681.
3. Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119:1647-1651.
4. Oberg K. Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol 2002; 14:38-45. The author presents a concise summary of different facets of carcinoid tumors.
5. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Ann Oncol 2001; 12 (Suppl 2):111-114.
6. Oberg K. Interferon in the management of neuroendocrine GEP-tumors. Digestion 2000; 62 (Suppl 1):92-97.
7. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin analogues. Digestion 2000; 62 (Suppl 1):84-91.
8. Quaedvlieg PFHJ, Visser O, Lamers CBHW, et al. Epidemiology and survival in patients with carcinoid disease in the Netherlands. Ann Oncol 2001; 12:1295-1300.
9. Filosso PL, Rena O, Donati G, et al. Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 2002; 123:303-309.
10. Tichansky DS, Cagir B, Borazzo E, et al. Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 2002; 45:91-97.
11. Lamberts SWJ, van der Lely A-J, de Herder WW, Hofland LJ. Drug therapy: octreotide. N Engl J Med 1996; 334:246-254.
12. de Herder WW, Lamberts SWJ. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 2002; 14:53-57.
13. Simula DV, Edwards WD, Tazelaar HD, et al. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002; 77:139-147.
14. Westberg G, Wangberg B, Ahlman H, et al. Prediction of prognosis by echocardiography in patients with midgut carcinoid. Br J Surg 2001; 88:865-872.
15. Khan MA, Herzog CA, St Peter JV, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite suppressant drugs. N Engl J Med 1998; 339:713-718.
16. McCann UD, Seiden LS, Rubin LJ, Ricaurte GA. Brain serctonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: a systematic review of the literature. JAMA 1997; 278:666-672.
17. Connolly HM, Schaff HV, Mullany CJ, et al. Surgical management of left-sided carcinoid heart disease. Circulation 2001; 104 (Suppl):136-140.
18. Narine KK, Dohmen PM, Daenen W. Tricuspid and pulmonary valve involvement in carcinoid disease. Tex Heart Inst J 2000; 27:405-407.
19. Wilhelmi M, Fritz MKH, Fischer S, et al. Triple valve replacement in a patient with severe carcinoid heart disease. Cardiovasc Surg 2002; 10:287-290.
20. Johnston SD, Johnston PW, O'Rourke D. Carcinoid constrictive pericarditis. Heart 1999; 82:641-643.
21. Kasi VS, Ahsanudin AN, Gilbert C, et al. Isolated metastatic myocardial carcinoid tumor in a 48-year-old man. Mayo Clin Proc 2002; 77:591-594. This is an interesting report of an asymptomatic patient with a myocardial carcinoid metastasis.
22. Pandya UH, Pellikka PA, Enriquez-Sarano M, et al. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol 2002; 40:1323-1332.
23. Quinlivan JK, Roberts WA. Intraoperative octreotide for refractory carcinoid-induced bronchospasm. Anesth Analg 1994; 78:400-402.
24. Kinney MAO, Warner ME, Nagorney DM, et al. Perianesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumors. Br J Anaesth 2001; 87:447-452.
25. Pandharipande PR, Reichard PS, Vallee MF. High gastric output as a perioperative sign of carcinoid syndrome. Anesthesiology 2002; 96:755-756.
26. Claure RE, Drover DD, Haddow GR, et al. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management. Can J Anaesth 2000; 47:334-337.
27. Vaughan DJA, Brunner MD. Anesthesia for patients with carcinoid syndrome. Int Anesthesiol Clin 1997; 35:129-142.
28. Graham GW, Unger BP, Coursin DB. Perioperative management of selected endocrine disorders. Int Anesthesiol Clin 2000; 38:31-67.
29. Cortinez FLI. Refractory hypotension during carcinoid resection surgery. Anaesthesia 2000; 55:505-506.
30. Vaughan DJA, Brunner MD. Awake fibreoptic intubation in a patient with carcinoid syndrome. Can J Anaesth 1998; 45:187-188.
31. Veall GRQ, Peacock JE, Bax NDS, Reilly CS. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth 1994; 72:335-341.
32. Botero M, Fuchs R, Paulus DA. Carcinoid heart disease: a case report and literature review. J Clin Anesth 2002; 14:57-63. This is a concise review of carcinoid heart disease.
33. Neustein SM, Cohen E. Anesthesia for aortic and mitral valve replacement in a patient with carcinoid heart disease. Anesthesiology 1995; 82:1067-1070.
34. Propst JW, Siegel LC, Stover EP. Anesthetic considerations for valve replacement surgery in a patient with carcinoid syndrome. J Cardiothorac Vasc Anesth 1994; 8:209-212.